1207852-93-4 Usage
Description
(2S,4S)-tert-butyl 2-(difluoromethyl)-4-hydroxypyrrolidine-1-carboxylate is a pyrrolidine derivative featuring a tert-butyl group at the 2-position, a difluoromethyl group also at the 2-position, and a hydroxy group at the 4-position. This carboxylate ester possesses a specific stereochemistry of (2S, 4S), which may contribute to its unique properties and potential applications.
Uses
Used in Pharmaceutical Industry:
(2S,4S)-tert-butyl 2-(difluoromethyl)-4-hydroxypyrrolidine-1-carboxylate is used as a potential pharmaceutical compound for its unique structural features. The presence of the difluoromethyl and hydroxy groups, along with the stereochemistry, may offer specific binding affinities or reactivity that could be exploited in the development of new drugs.
Used in Agrochemical Industry:
In the agrochemical sector, (2S,4S)-tert-butyl 2-(difluoromethyl)-4-hydroxypyrrolidine-1-carboxylate may serve as a precursor or intermediate in the synthesis of agrochemical products. Its unique structural elements could be key in creating new pesticides, herbicides, or other agricultural chemicals that are more effective or have fewer environmental impacts.
Further research is necessary to fully explore and understand the potential uses and effects of (2S,4S)-tert-butyl 2-(difluoromethyl)-4-hydroxypyrrolidine-1-carboxylate in these industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1207852-93-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,7,8,5 and 2 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1207852-93:
(9*1)+(8*2)+(7*0)+(6*7)+(5*8)+(4*5)+(3*2)+(2*9)+(1*3)=154
154 % 10 = 4
So 1207852-93-4 is a valid CAS Registry Number.
1207852-93-4Relevant articles and documents
6 SUBSTITUTED 2-HETEROCYCLYLAMINO PYRAZINE COMPOUNDS AS CHK-1 INHIBITORS
-
Page/Page column 120-121, (2010/04/03)
The present invention is directed to compounds of formula (I), and pharmaceutically acceptable salts thereof, their synthesis, and their use as CHK-1 inhibitors.
